trump glp 1 GLP-1 price reduction: President announces agreement on drugs Trump's GLP-1 deals leaves questions

doi: 10.1016/j.eprac.2023.11.007 64 MoseleyKF

Sitagliptin, the first developed inhibitor, has a triazolopiperazine structure, while vildagliptin and saxagliptin have a cyanopyrrolidine structure

In summary, exenatide was a trailblazer

After a few years of injectable dominance, oral formulations are emerging as a game-changer for adherence and ease of use thanks to their lack of cold-chain requirement, but also a game-changer for their ability to unlock the long-term maintenance opportunity [14]

Treatment duration in older patients should balance weight loss benefits against the risk of excessive lean mass depletion